Study confirms higher risk of dengue in kids who got Sanofi vaccine


CHICAGO (Reuters) – An analysis of data on Sanofi’s dengue vaccine, which has been given to more than 800,000 school children in the Philippines, confirms it increases the risk of hospitalization and severe dengue in those who had never previously been infected with the mosquito-borne virus.

FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

The findings, published on Wednesday in the New England Journal of Medicine, offer fresh support for the World Health Organization…



Read More Here

Be the first to comment on "Study confirms higher risk of dengue in kids who got Sanofi vaccine"

Leave a comment

Your email address will not be published.


*